Warhound Valued at $1.2 Billion After Raising $200 Million for Engineered Military Dogs

For the first time, the U.S. military and law enforcement agencies may have a domestic supply of specialized working dogs that are genetically optimized for performance. The initiative, led by a new venture called Warhound, aims to reduce the nation's reliance on foreign imports for these critical assets. This shift could alter the operational costs and logistical challenges associated with maintaining the current canine workforce for defense and emergency response.

Warhound emerged from stealth on Thursday with a significant capital injection of $200 million. The funding round values the company at $1.2 billion. The investor group includes major venture capital firms such as Sequoia and 8VC, as well as Corner Ventures. A notable participant is In-Q-Tel, a venture firm supported by the CIA and other U.S. intelligence agencies. This financial backing signals strong confidence in the commercial viability of engineered biological assets in the defense sector.

The core of the business proposition addresses a specific supply chain weakness. According to the launch announcement, over 80% of the U.S. military's working dogs are currently sourced from Europe. Furthermore, the company notes that less than half of these imported animals are ultimately fit for service. This dependency creates a logistical bottleneck and highlights a gap in domestic production that Warhound intends to fill.

The venture is a collaboration between Ben Lamm of Colossal Biosciences and Palmer Luckey, the founder of Anduril. Lamm stated that he met Luckey at a conference roughly a year ago, where Luckey expressed a desire to see more innovation in the field of military working dogs. Following that meeting, Lamm investigated the breeding practices of current working dogs. He found that many fail training due to inherited health issues, including poor eyesight, hip dysplasia, muscle atrophy, and a higher likelihood of cancer.

Warhound plans to engineer dogs with specific traits suited for demanding missions. The team is using cell lines from top-performing breeds, specifically the Belgian Malinois and the German Shepherd, which are stored in a biobank. The process involves gene editing to add performance-enhancing traits and remove genes associated with health liabilities. The goal is to create a new type of dog that is healthier, longer-lived, and better equipped for tasks such as bomb detection and search operations.

Anduril will play a crucial role by providing the hardware and software components. This includes protection vests, goggles, and other gear designed to assist both the dogs and their handlers. Lamm described the concept as adding technology on top of the dog rather than inside it. For instance, bulletproof vests equipped with data sensors could send real-time information to handlers, improving situational awareness and coordination during operations.

The timeline for deployment is aggressive. Lamm indicated that the first batch of dogs is about to be cloned and incubated. Births are expected in early next year, with the animals potentially entering service within two years. Viagen, another company owned by Colossal, will handle the cloning process. Lamm noted that Viagen’s technology has a high success rate, which is already used in Colossal’s programs for protecting endangered species.

While the pricing model is not yet defined, the company expects to sell to first responders, the Department of Defense, military service groups, and police forces. Lamm confirmed that the company has briefed various government groups about the business. Luckey serves as a partner in the venture but does not hold equity. Colossal Biosciences holds equity and supports the operation by licensing its technology to Warhound.

The American Humane Society is working with Warhound to certify the training program for the new dogs. The Society stated that it looks forward to ensuring the animals are treated humanely. There is also a plan for retired military dogs to enter the Society’s reunification program, which provides homes for retired service animals. This partnership is designed to address civilian safety concerns and ensure ethical management of the enhanced workforce.

The stakes for the defense market are high as the U.S. seeks to modernize its biological assets. By combining genetic engineering with advanced tech hardware, Warhound is positioning itself to solve a long-standing logistical problem. The $1.2 billion valuation reflects the market's belief that this hybrid approach to military support will become a standard requirement for future defense budgets.